Dizal Pharmaceutical Co Ltd
SSE:688192
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dizal Pharmaceutical Co Ltd
SSE:688192
|
CN |
|
HB Fuller Co
NYSE:FUL
|
US |
|
Norditek Group AB
STO:NOTEK
|
SE |
|
C
|
Corporate Travel Management Ltd
OTC:CTMLF
|
AU |
|
Ramky Infrastructure Ltd
NSE:RAMKY
|
IN |
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
DK |
|
M
|
Madrigal Pharmaceuticals Inc
SWB:YDO1
|
US |
|
Turaco Gold Ltd
OTC:TCGDF
|
AU |
|
China Shenhua Energy Co Ltd
SSE:601088
|
CN |
|
Orell Fuessli AG
SIX:OFN
|
CH |
|
Assure Holdings Corp
OTC:IONM
|
US |
|
SEB SA
PAR:SK
|
FR |
|
S
|
Severn Trent PLC
OTC:STRNY
|
UK |
|
T
|
Tencent Holdings Ltd
DUS:NNN1
|
CN |
|
T
|
TIS Inc
TSE:3626
|
JP |
|
Tomy Co Ltd
TSE:7867
|
JP |
|
Cheil Grinding Wheel Ind Co Ltd
KRX:001560
|
KR |
|
S
|
Summa Defence Oyj
OMXH:SUMMA
|
FI |
|
O
|
O'Reilly Automotive Inc
LSE:0KAB
|
US |
|
T
|
Tai Cheung Holdings Ltd
HKEX:88
|
HK |
|
MSCI Inc
NYSE:MSCI
|
US |
|
T
|
TotalEnergies SE
XHAM:TOTB
|
FR |
|
G
|
GoDaddy Inc
SWB:38D
|
US |
|
A
|
Amgen Inc
DUS:AMG
|
US |
Bankruptcy Probability
Dizal Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dizal Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
D
|
Dizal Pharmaceutical Co Ltd
SSE:688192
|
31.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
509.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
96.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
96.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
38.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dizal Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dizal Pharmaceutical Co Ltd has total debt of 973.5m CNY. This includes both short-term (48.9m CNY) and long-term (924.6m CNY) debt.
You can find a full breakdown on its Balance Sheet.